BACKGROUND - As we noted in prior health care alerts in 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) significantly overhauled the federal law that governs the confidentiality of substance use...more
On this week’s episode, Carla DewBerry and Sarah Carlins discuss a recent California Federal District Court decision in David Wit v. United Behavioral Health, in which the court found that the defendant insurer violated ERISA...more
12/11/2020
/ Denial of Insurance Coverage ,
Employee Retirement Income Security Act (ERISA) ,
Fiduciary Duty ,
Health Claims ,
Health Insurance ,
Health Plan Sponsors ,
Insurance Claims ,
Insurance Industry ,
Insurance Litigation ,
Mental Health ,
Plan Administrators ,
Scope of Coverage ,
Standard of Care ,
Substance Abuse
In this week’s episode, Carla DewBerry and Kelsey Jernigan discuss issues in mental health parity in the context of recent California legislation. In particular, the presenters discuss how a new California bill has sparked a...more
9/29/2020
/ Affordable Care Act ,
Denial of Insurance Coverage ,
Essential Health Benefits ,
Health Care Providers ,
Health Insurance ,
Healthcare Reform ,
Medical Necessity ,
Mental Health ,
Mental Health Parity Rule ,
Pending Legislation ,
Substance Abuse
On October 24, 2018, President Trump signed into law comprehensive opioid legislation known as the “Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act” or the...more
This is the first episode in a series focused on the legal issues surrounding the nationwide opioid crisis. To begin the series, Carla DewBerry discusses the laws and regulations impacting health care providers caring for...more
2/28/2018
/ Attorney General ,
Centers for Disease Control and Prevention (CDC) ,
Controlled Substances ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Health Care Providers ,
Healthcare Fraud ,
Kickbacks ,
Medical Monitoring ,
Opioid ,
OxyContin ,
Pain Management ,
Pharmaceutical Distribution ,
Pharmaceutical Industry ,
Prescription Drugs ,
SAMHSA ,
Substance Abuse